Oncogenes y Dianas Efectoras
PANCCUN
Karolinska University Hospital
Estocolmo, SueciaPublicaciones en colaboración con investigadores/as de Karolinska University Hospital (1)
2022
-
Identifying FGFR2 fusions/rearrangements in cholangiocarcinoma patients using a novel cfDNA algorithm for treatment with RLY-4008, a highly selective irreversible FGFR2 inhibitor
European Journal of Cancer, Vol. 174, pp. S116